Navigation Links
MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting

65.1- (Infinity)) compared to 72.7 weeks (95% CI, 57.7-84.3) for patients who did not receive Gliadel. One- and 2- year survival rates were also increased with the addition of Gliadel (81% vs. 67% and 44% vs. 27%, respectively). A Cox proportional hazards model accounting for the effects of the Recursive Partitioning Analysis (RPA) class was performed, and the effect of Gliadel treatment on survival was found to approach significance (p less than 0.055). Adverse events were similar in patients treated with or without Gliadel and included thrombocytopenia, leukopenia, seizures, fatigue, and gastrointestinal.

Irofulven

Results of a Randomized Phase 2 Trial of Irofulven in Hormone Refractory Prostate Cancer (HRPC) Patients who Failed First-line Docetaxel Treatment

Updated results of a randomized, 3-arm phase 2 study of irofulven + prednisone +/- capecitabine compared to mitoxantrone + prednisone in patients with HRPC were presented in a poster discussion on Saturday, June 2, 2007. A total of 137 patients with documented resistance to first-line treatment with docetaxel were stratified by presence or absence of disease related pain at study entry and assigned to treatment in a 2:2:1 manner (i.e. 4/5 patients received an irofulven-containing regimen). Although the study was not designed for a statistical comparison of survival, there was a consistent trend toward increased survival in the irofulven arms vs. mitoxantrone over the entire study period and through last follow-up. The observed median overall survival was 10.6 months for patients treated with irofulven + prednisone, 9.4 months for irofulven + capecitabine + prednisone, and 7.3 months for mitoxantrone + prednisone. Similarly, patients with disease-related pain at baseline receiving irofulven + prednisone had a median survival of 8 months vs. 5.5 months for those patients receiving mitoxantrone + prednisone. PSA response was noted in 22% of patients receiving irofulven + capecitabine + predn
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. MGI Pharma Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
5. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
8. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
9. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
10. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
11. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
Post Your Comments:
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical ... new drugs and tests, and this is ... instruments that can assist them. This according to ... Information said instruments such as mass spectrometry, ... in the identification of drug targets and ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ...  to their offering.       ... or gene silencing involves the use of ... cell, this material is processed into short ...
(Date:5/28/2015)... ( http://maetrics.com ), a leading international consulting firm focused ... conference, "The cost of non-compliance -- How new regulation is ... Zurich . Hosted by Maetrics ... -based team, experts provided insights on the impact ... exclusive local audience. The event was held in conjunction ...
Breaking Medicine Technology:Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... N.J., Sept. 27 The American Chemical Society, Informex, and ... to partner in hosting the , ACS Careers Virtual Career ... virtual event, to be held November 2 -3, ... scientific society, chose to work with Informex , the ...
... healthcare market research company ... Online Health Video : Understanding Consumption Patterns to ... health video and the impact of this format on ... significantly among U.S. consumers online for prescription drug information ...
Cached Medicine Technology:Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 2Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 3Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 4New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format 2
(Date:5/28/2015)... Falls Church, VA (PRWEB) May 28, 2015 ... Roadmap to the 351(k) Application Process, **FDAnews Webinar**, ... p.m. EDT, [http://www.fdanews.com/BiosimilarsApproval , On June ... and expertise of two leading intellectual property attorneys ... the webinar Success Strategies for Biosimilars Approval: A ...
(Date:5/28/2015)... 28, 2015 On Sunday, June 21, ... a team event to honor the strength, passion and ... summer solstice, the duration of this sunrise-to-sunset event symbolizes ... and their caregivers. Participants raise funds and awareness to ... Alzheimer’s Association. , Teams are encouraged to create their ...
(Date:5/28/2015)... 28, 2015 Park Cities Pet Sitter is ... Training class starting Saturday, June 6th at 10:30am. ... 5831 McCommas Blvd in Dallas, with a maximum of six ... for five weeks, with no class being held over the ... $135. , In this Intermediate-to-Advanced level class, dogs will solidify ...
(Date:5/28/2015)... Restricting access to firearms for people ... that more clearly define alcohol misuse should be developed ... research and public policies by the UC Davis Violence ... 30 in the peer-reviewed journal Preventive Medicine , ... alcohol misuse in association with firearm access and use, ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 The Boys ... of $2,500 from Horizon Blue Cross Blue Shield of New ... golfer Natalie Gulbis, the club can receive much more support ... by Acer. , A former Boys & Girls Club member ... in Sacramento, California, Ms. Gulbis has accepted the Horizon Blue ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 2Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 4Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3
... spinal fusions, but experts worry about costs and complications, , ... agent that stimulates the creation of new bone as part ... United States, although costs and some complication rates also appear ... , The therapeutic agent, known as bone-morphogenic protein, or BMP, ...
... can cause liver damage, even death, if used improperly , ... Tuesday to lower the maximum dose of over-the-counter acetaminophen -- ... medications. , The advisers, vote followed the release of a ... that severe liver damage and even death can result from ...
... how patients interpret results, researchers say , TUESDAY, June ... cancer appears to offer some benefits to patients, according ... online test among 44 smokers. , "Up until now ... You see a professional genetics counselor, undergo a battery ...
... 30 At the 8th Annual Spirit of Entrepreneurship ... Texas (EFNT) recognized The Beryl Companies, the nation,s leading ... as the North Star 2009 Inductee. This award is ... show the importance of giving back to our community ...
... lead to serious injury , , , CHICAGO, ... of skateboarding. They learn to master their skills of "riding ... College of Foot and Ankle Surgeons (ACFAS), such tricks, while ... ankle injuries. , , Foot and ankle surgeons ...
... , VIENNA, Va., June 30 CEL-SCI Corporation ... immunotherapy company, today announced that it has completed a registered ... million before deducting placement agent fees and estimated offering expenses. ... 24, 2009 when the Company entered into definitive agreements, was ...
Cached Medicine News:Health News:Assessment of Bone Growth Stimulator Is Mixed 2Health News:Assessment of Bone Growth Stimulator Is Mixed 3Health News:FDA Advisers Urge Smaller Doses of Acetaminophen 2Health News:FDA Advisers Urge Smaller Doses of Acetaminophen 3Health News:Online Genetic Testing Appears to Have Benefits 2Health News:Beryl Receives Entrepreneurs Foundation of North Texas North Star Recognition 2Health News:Surgeons Warn: Skateboarding Tough on Feet, Ankles 2Health News:CEL-SCI Completes $5.85 Million Registered Direct Offering 2Health News:CEL-SCI Completes $5.85 Million Registered Direct Offering 3
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The ThermoWrap™ enables true normothermia (36.5°C - 37.5°C), induced hypothermia and precise rewarming....
The full body blanket provides coverage to the entire patient....
Medicine Products: